Automated Whole-Body Bone Lesion Detection for Multiple Myeloma on 68Ga-Pentixafor PET/CT Imaging Using Deep Learning Methods.
Lina XuGiles TettehJana LipkovaYu ZhaoHongwei LiPatrick ChristMarie PiraudAndreas BuckKuangyu ShiBjoern H MenzePublished in: Contrast media & molecular imaging (2018)
The identification of bone lesions is crucial in the diagnostic assessment of multiple myeloma (MM). 68Ga-Pentixafor PET/CT can capture the abnormal molecular expression of CXCR-4 in addition to anatomical changes. However, whole-body detection of dozens of lesions on hybrid imaging is tedious and error prone. It is even more difficult to identify lesions with a large heterogeneity. This study employed deep learning methods to automatically combine characteristics of PET and CT for whole-body MM bone lesion detection in a 3D manner. Two convolutional neural networks (CNNs), V-Net and W-Net, were adopted to segment and detect the lesions. The feasibility of deep learning for lesion detection on 68Ga-Pentixafor PET/CT was first verified on digital phantoms generated using realistic PET simulation methods. Then the proposed methods were evaluated on real 68Ga-Pentixafor PET/CT scans of MM patients. The preliminary results showed that deep learning method can leverage multimodal information for spatial feature representation, and W-Net obtained the best result for segmentation and lesion detection. It also outperformed traditional machine learning methods such as random forest classifier (RF), k-Nearest Neighbors (k-NN), and support vector machine (SVM). The proof-of-concept study encourages further development of deep learning approach for MM lesion detection in population study.
Keyphrases
- pet ct
- deep learning
- convolutional neural network
- machine learning
- artificial intelligence
- positron emission tomography
- loop mediated isothermal amplification
- real time pcr
- label free
- multiple myeloma
- healthcare
- big data
- ejection fraction
- mass spectrometry
- photodynamic therapy
- poor prognosis
- postmenopausal women
- single cell
- high throughput
- end stage renal disease
- soft tissue
- bone loss
- body composition
- patient reported outcomes
- prognostic factors
- single molecule
- fluorescence imaging
- social media